Australia markets close in 51 minutes

Viridian Therapeutics, Inc. (1S1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
11.20+0.10 (+0.90%)
At close: 08:00AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-218,125
-237,734
-129,874
-79,413
-110,715
-
Depreciation & amortisation
562
522
255
120
239
-
Stock-based compensation
64,644
67,172
19,765
14,465
3,645
-
Change in working capital
-8,120
-9,425
15,962
1,724
4,427
-
Accounts receivable
-
-
-
-
99
-84
Accounts payable
-4,911
-12,040
11,524
1,655
-426
-
Other working capital
-168,203
-185,068
-94,635
-54,919
-29,821
-
Other non-cash items
6,615
6,603
264
7,485
72,569
-
Net cash provided by operating activities
-167,420
-184,170
-93,838
-54,581
-29,779
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-898
-797
-338
-42
-
Purchases of investments
-556,209
-407,880
-223,264
-188,431
-81,807
-
Sales/maturities of investments
332,990
314,526
108,935
114,398
2,000
-
Other investing activities
-
-
-
-
-3
-
Net cash used for investing activities
-224,002
-94,252
-115,126
-74,292
-50,481
-
Cash flows from financing activities
Debt repayment
-
-
-
0
-10,293
-2,333
Common stock issued
311,334
125,069
291,874
114,242
25,104
-
Other financing activities
-
-12,315
-22,510
-8,278
-6,223
-
Net cash used provided by (used for) financing activities
394,548
225,670
322,244
125,275
101,311
-
Net change in cash
3,126
-52,752
113,280
-3,598
21,051
-
Cash at beginning of period
88,515
155,579
42,299
45,897
24,846
-
Cash at end of period
91,641
102,827
155,579
42,299
45,897
-
Free cash flow
Operating cash flow
-167,420
-184,170
-93,838
-54,581
-29,779
-
Capital expenditure
-
-898
-797
-338
-42
-
Free cash flow
-168,203
-185,068
-94,635
-54,919
-29,821
-